Can These Stocks Provide Investors with Further Gains?

NEW YORK, NY / ACCESSWIRE / May 22, 2015 / The economy continues to display immense uncertainty with deteriorating economic indicators as higher highs in major indexes are obtained with declining volume and with great caution, experiencing insignificant breakouts that usually do not accompany healthy markets. These factors have forced the Fed to move the goal post once again for its decision to raise rates, as announced by the FOMC Minutes on Wednesday. This uncertainty has confused both analysts and investors.

The quandary comes as no real surprise to us; nor should it surprise our newsletter members. We had anticipated this delay and in fact told our readers that not only would there not be a rising of rates, but there will be a new round of quantitative easing in the near future. In our most recent coverage of the economy we emphasized the following: "we continue to hold a negative outlook on equity markets as overvalued conditions present limited upside opportunity with significant downside risk, making long-term equity holdings a very risk bet." We stand by that sentiment and can't help but suggest that there exists significant risk for downside volatility.

To receive Free Market Forecasts along with NASDAQ/NYSE Trade Alerts CLICK HERE.

On May 6th, 2015 our NASDAQ/NYSE Investor Service alerted MagneGas Corporation (NASDAQ: MNGA) (VIEW ALERT HERE) to our readers resulting in a one day maximum gain opportunity of 27% from an alert price of $0.74 to a day high of $0.94. Realizable gains attainable from the alert that day to the majority of our members was 16%. After the initial alert we stated the following: "MNGA closed Wednesday's trading session at 0.82, above its open, at a level that could be an area of support for a potential next wave of gains. We believe MNGA could possibly provide investors with further upside opportunity." Yesterday, MNGA reached a market valuation of $1.58, up more than 113% from our initial alert price. Despite multiple opportunities to realize these gains (as many of our readers were able to) our gain tracker on our newsletter only accounts for 16% gains. The reason for this is because at the time of our alert the rally exhausted the full gain potential indicated in the due diligence. We are continuing monitoring MNGA for future entry opportunities and will alert our free members at that time.

To Receive Alerts Like MNGA Before They Rally CLICK HERE.

Prima Biomed Ltd. (PBMD) has showcased its momentum in recent sessions with a recent pullback that has only served to highlight the tremendous upside opportunity inherent in the company. PBMD has reached as high as 6.48 on Wednesday which means that current pricing of around 3.05 after yesterday's massive slide of more than 48% presents investors with potentially a great opportunity for a swing trade for upside opportunity. The company recently released positive data from its Phase II CAN-003 ovarian cancer clinical trial which sparked the initial momentum and rally. This sent the stock soaring 268%, pushing valuation to more than $6. We are continuously monitoring PBMD for our free members and will alert PBMD once an entry opportunity is presented that pinpoints increased risk-adjusted opportunity for gains.

Is PBMD Going Higher? To Receive Updates On PBMD CLICK HERE.

RADA Electronic Industries Ltd. (RADA) continues to show explosive daily volatility with recent trading pushing daily volume well over 138,000 shares, as of Thursday. This could be the start of the great run by RADA which has seen strong consolidation below 3.00 since the end of March. The stock put on a spectacular show on March 23rd, opening at 1.71 and rallying to a day high of 3.20 for a one-day gain opportunity of 87%. This was one of the biggest one-day rallies for RADA and the play has been building up strong upward momentum since from what could be a level of strong support. RADA was alerted to our free members on Friday at 9:35 AM ET.

To Receive Alerts Like RADA Before They Rally CLICK HERE.

AVEO Pharmaceuticals, Inc. (AVEO) recently delivered 90% maximum gain opportunity after opening at 1.84 and subsequently rallying to a day high of 3.50. This was a breakout performance that had surpassed the established 12-month ceiling of 2.17. The strong trading day also created new milestones for other technicals, including a 94 million share volume breakout. AVEO's 90% gain opportunity came on May 21st, two full days after the company announced the final results from its TIVO-1 extension study involving patients with advanced renal cell carcinoma. The positive results have resulted in a progression to the next step in the company's Phase 3 TIVO-1 first-line RCC study which will be presented at the 2015 American Society of Clinical Oncology (ASCO) Annual Meeting.

As always, we encourage readers to keep abreast of our updates. AVEO's 90% gain opportunity could experience a near-term consolidation. We are closely following AVEO and will alert our free members once the company presents a potential entry opportunity to witness risk-adjusted gains.

What's Next For AVEO? To Receive Updates OnAVEO CLICK HERE.

CLICK HERE To Learn More About Our NASDAQ/NYSE Alert Service

About UltimateStockAlerts.com

UltimateStockAlerts.com covers NASDAQ and NYSE listed companies that are overlooked and undervalued by Wall Street. Investors can choose to receive trading strategies via text message (SMS) or email. To receive free text message alerts, on your phone, compose a new text message to the number 555-888 with the message ULTIMATE. For more information visit www.UltimateStockAlerts.com.

Disclosure: Information, opinions and analysis contained herein are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We accept no liability for any losses arising from an investor's reliance on or use of this report. This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. UltimateStockAlerts.com has not been compensated nor expects to receive any compensation for distribution of our opinions and publicly available information for PBMD, RADA, nor AVEO as of 05/22/2015. Our holding company has been compensated forty-five thousand dollars via bankwire for distribution of our opinions and publicly available information for MNGA by ACS Financial Consulting. Certain information included herein is forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein. Please visit www.UltimateStockAlerts.com website, for complete risks and disclosures.

SOURCE: UltimateStockAlerts.com

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.